TTrialPathMatch Me to Trials
← Back to trials
RecruitingHypothyroidism

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Eligible age

18–75 yrs

Accepts

All genders

Locations

31 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism and are currently stabilized (i.e., in-range thyroid-stimulating hormone \[TSH\]) on synthetic T4 treatment. This study will also therefore evaluate the efficacy and safety of dose conversion from synthetic T4 therapy to Armour Thyroid therapy.

Sponsor: AbbVie

You may qualify if…

  • Have a diagnosis of primary hypothyroidism made \>= 12 months prior to Screening.
  • Be on continuous thyroid replacement therapy of synthetic T4 for primary hypothyroidism for at least 12 months immediately prior to the Screening Visit.
  • Be on a stable FDA-approved daily dose of synthetic T4 prior to the Screening visit, and must be taking synthetic T4 dose of at least 25 mcg at Screening visit. Must enter the study using the same stable dose to determine dose conversion.
  • Documentation of 1 in-range thyroid-stimulating hormone (TSH) (i.e., within 0.45 - 4.12 mIU/L, inclusive) at Screening and at least 1 additional in range TSH (i.e., within 0.45 - 4.12 mIU/L, inclusive) taken at a minimum of 6 weeks and a maximum of 12 months prior to Screening.

You may not qualify if…

  • Any clinical condition or previous surgery that might affect the absorption, distribution, biotransformation, or excretion of Armour Thyroid or synthetic T4.
  • History of alcohol or other substance abuse within the previous 6 months prior to the Screening.
  • Known or suspected allergy or intolerance to any ingredients of Armour Thyroid, including its excipients, synthetic T4, other thyroid replacement medications, or pork products.

Where it's recruiting

Alabama

Birmingham

California

Bonita · Burbank · Concord · Encinitas

Connecticut

Bridgeport

Florida

Clearwater · Cooper City · Fleming Island · Fort Lauderdale

Georgia

Atlanta · Canton · Columbus · Lawrenceville

Hawaii

Honolulu

Idaho

Idaho Falls

Illinois

Chicago

Iowa

Council Bluffs · West Des Moines

Kansas

Topeka

Kentucky

Louisville

Louisiana

Baton Rouge · Metairie

Source: ClinicalTrials.gov · NCT06345339 · last updated 2026-01-05